Ελληνικά
The HearVir project aims at a better understanding and thus an improved diagnostic of idiopathic inflammatory heart diseases by using a combination of high-throughput sequencing, culturing, and epidemiology. Among inflammatory heart diseases, myocarditis and pericarditis are characterized by an inflammation of the myocardium and the pericardial sac, respectively. Clinical manifestations of myopericarditis are variable from acute to chronic, asymptomatic to very severe and even life-threatening forms. Among known etiological infectious agents, viruses (in mono or co-infections) largely prevail over other causes of myocarditis. However, more than 50 % of the cases still remain idiopathic i.e., diagnostic tests fail in determining the etiological cause of disease. Although current methods are good for detecting known viruses, they are very ineffective for discovering novel ones. Diagnosing novel viral infections is difficult mainly due to our inability to culture viruses on cell lines in the laboratory, the small size and the low nucleic acid content of viruses, and the lack of a conserved genetic element among viral genomes that could be used for PCR-based analyses. Since the past 10 years, metagenomics, the sequenced-based analysis of the whole collection of genomes directly isolated from a sample, has emerged has a powerful tool for discovering completely new viruses or viruses that escaped current diagnostic screening tests. In this project, we propose to use a blind metagenomic approach for a complete description of the RNA viruses associated with idiopathic myopericarditis. Once identified and confirmed in the original sample, this project aims to link the presence of this (these) virus(es) to the pathology throughout an exhaustive epidemiological study performed on a 3-year cohort of patients with myopericarditis. In this project, we also want to bring some collective efforts on culture by using the latest developments of the domain in order to both produce antibodies that can retrospectively be used for epidemiology and to generate an animal model for studying the pathophysiology of the viral infection. The HeartVir project reunites together and toward a common objective, a strong and complementary team composed of scientific experts in the field of characterization of RNA viruses from complex samples, viral metagenomics, physiopathology and animal models of viral infections, associated with among the best physicians in cardiology and infectious diseases.
